Clinical trials
Withdrawn Phase 3 Urinary Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2023 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical Enterprises Europe B.V. | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Bioniche Life Sciences Inc. | 1 |
| Brigham and Women's Hospital | 1 |
| Relmada Therapeutics, Inc. | 1 |
| Second Xiangya Hospital of Central South University | 1 |
| The University of Texas Health Science Center at San Antonio | 1 |
| University of Southern California | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 9 |
| Non-Muscle Invasive Bladder Neoplasms | 4 |
| Neoplasms | 2 |
| Urologic Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Carcinoma in Situ | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Esthesioneuroblastoma, Olfactory | 1 |
| Head and Neck Neoplasms | 1 |
| Neoplasms by Site | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.